Cardiopulmonary and behavioral effects of combinations of acepromazine/butorphanol and acepromazine/oxymorphone in dogs

J. L. Cornick From the Department of Small Animal Medicine and Surgery, Texas Veterinary Medical Center, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843.

Search for other papers by J. L. Cornick in
Current site
Google Scholar
PubMed
Close
 DVM, MS
and
S. M. Hartsfield From the Department of Small Animal Medicine and Surgery, Texas Veterinary Medical Center, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843.

Search for other papers by S. M. Hartsfield in
Current site
Google Scholar
PubMed
Close
 DVM, MS

Click on author name to view affiliation information

Summary

Cardiopulmonary and behavioral effects of the following tranquilizer-opioid drug combinations were compared in conscious dogs: acepromazine (0.22 mg/kg of body weight, iv) and butorphanol (0.22 mg/kg, iv); acepromazine (0.22 mg/kg, im) and butorphanol (0.22 mg/kg, im); and acepromazine (0.22 mg/kg, iv) and oxymorphone (0.22 mg/kg, iv). Marked sedation and lateral recumbency that required minimal or no restraint was achieved with every drug combination. Analgesia was significantly better in dogs receiving oxymorphone than in dogs receiving butorphanol, as evaluated by response to toe pinch. There were no significant differences between the effects of the 3 drug combinations on heart rate, respiratory rate, arterial blood pressure, body temperature, and arterial pH, PCO2, PO2, and bicarbonate concentration. Heart rate, respiratory rate, and systolic arterial pressure decreased significantly over time with all drug combinations. Total recovery time (minutes from the initial injection to standing) was significantly longer in the dogs given acepromazine and oxymorphone.

Summary

Cardiopulmonary and behavioral effects of the following tranquilizer-opioid drug combinations were compared in conscious dogs: acepromazine (0.22 mg/kg of body weight, iv) and butorphanol (0.22 mg/kg, iv); acepromazine (0.22 mg/kg, im) and butorphanol (0.22 mg/kg, im); and acepromazine (0.22 mg/kg, iv) and oxymorphone (0.22 mg/kg, iv). Marked sedation and lateral recumbency that required minimal or no restraint was achieved with every drug combination. Analgesia was significantly better in dogs receiving oxymorphone than in dogs receiving butorphanol, as evaluated by response to toe pinch. There were no significant differences between the effects of the 3 drug combinations on heart rate, respiratory rate, arterial blood pressure, body temperature, and arterial pH, PCO2, PO2, and bicarbonate concentration. Heart rate, respiratory rate, and systolic arterial pressure decreased significantly over time with all drug combinations. Total recovery time (minutes from the initial injection to standing) was significantly longer in the dogs given acepromazine and oxymorphone.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 561 561 125
PDF Downloads 37 37 7
Advertisement